📢 Latest Update: UGC Discontinues CARE Journal Listing: New Guidelines for Selecting Peer-Reviewed Journals View Now

[email protected] +91 1204781263, +91 9218093694
Emerging Trends in Personalized Medicines Cover

Emerging Trends in Personalized Medicines

E-ISSN: 3049-1347 | Peer-Reviewed Journal (Refereed Journal) | Hybrid Open Access

About the Journal

Emerging Trends in Personalized Medicines [3049-1347(e)] is a peer-reviewed online journal launched in 2024 that aims to unite all facets of personalized medicine under one platform. Case studies, well-liked articles, research papers, and reviews are all published by it. Molecular and translational sciences, systems biology pharmacogenomics/proteomics, omics association analysis, therapies and diagnostics, discussions of regulatory, social, ethical, and policy concerns, etc. are only a few of the scientific disciplines that are advanced by the publication of papers in the interdisciplinary journal personalized medicine. Researchers are expected to report their theoretical and empirical findings in as much detail as appropriate. As a result, there is no restriction on the paper’s length. To enable the replication of the findings, appropriate theoretical and simulation information must be available.

View full focus & scope More

Journal Information

Title: Emerging Trends in Personalized Medicines
Abbreviation: etpm
Issues Per Year: 2 Issues
E-ISSN: 3049-1347
Publisher: STM Journals, An imprint of Consortium e-Learning Network Pvt. Ltd.
DOI: 10.37591/ETPM
Starting Year: 2024
Subject: Personalized Medicines
Publication Format: Hybrid Open Access
Language: English
Copyright Policy: CC BY-NC-ND
Type: Peer-reviewed Journal (Refereed Journal)

Address:

STM Journals, An imprint of Consortium e-Learning Network Pvt. Ltd. A-118, 1st Floor, Sector-63, Noida, U.P. India, Pin - 201301

Editorial Board

View Full Editorial Board

etpm maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Editor in Chief

Editor

Dr. Amit Chandna, Principal

Pt.B.d. Sharma University of health sciences ,Rohtak, Haryana, India, 132001

Email :

Latest Articles

Ahead of Print

Personalized Medicine: the impact of ferrofluids, clinical procedures, strategies, applications,challenges, current trends, and reseach opportunities.

Personalized medicine has shown progressive development and evolution in health care systems.

personalized medicine, magnetic nanoparticles, ferrofuilds , streamlime approach, emerging technologies.

Personalized Medicine: the impact of ferrofluids, clinical procedures, strategies, applications, challenges, current trends, and research opportunities.

Personalized medicine has shown progressive development and evolution in health care systems.

personalized medicine, magnetic nanoparticles, ferrofuilds , streamlime approach, emerging technologies.

Personalized Medicine: the impact of ferrofluids, clinical procedures, strategies, applications, challenges, current trends, and research opportunities.

Personalized medicine has shown progressive development and evolution in health care systems.

personalized medicine, magnetic nanoparticles, ferrofuilds , streamlime approach, emerging technologies.

AI-Driven Pharmacogenomics and Precision Medicine: Future of Personalized Therapy

Pharmacogenomics and artificial intelligence (AI) are emerging as important drivers of precision medicine, enabling healthcare systems to adopt individualized therapeutic approaches.

Artificial intelligence, pharmacogenomics, precision medicine, personalized therapy, machine learning

A Review on Transforming Patient Pathways: The Impact of Pharmaceutical Software on Drug Manufacturing and Safety Monitoring

The development, production, and safety monitoring of pharmaceuticals are being revolutionized by incorporating digital technologies.

Digital transformation, Drug manufacturing, Patient pathways, Pharmaceutical software, Safety monitoring

A Review on the Interconnection Between Drug Design and Controlled Drug Delivery Systems

Drug discovery and delivery are two branches of science that have historically developed as independent areas of discovery – one focused on optimizing the properties of molecules for biological activity, and the other on controlling the rate, site, and duration for drug release.

ADMET, artificial intelligence, controlled drug delivery, drug design, molecular modeling, nanotechnology